ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BVP Bioscience Vct

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type Share ISIN Share Description
Bioscience Vct LSE:BVP London Ordinary Share GB0031256109 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Issue of Supplementary Prospectus

25/03/2022 10:00am

GlobeNewswire Inc.


Bioscience Vct (LSE:BVP)
Historical Stock Chart


From Mar 2022 to Mar 2025

Click Here for more Bioscience Vct Charts.
Issue of Supplementary Prospectus

25 March 2022

Seneca Growth Capital VCT Plc

Issue of Supplementary Prospectus

The Board of Seneca Growth Capital VCT Plc (the “Company”) is pleased to announce that the Company has today published a supplementary prospectus (the “Supplementary Prospectus”) relating to the offer of subscription for B ordinary shares of 1p each in the Company, details of which were set out in a prospectus issued by the Company on 29 October 2021 (the “Offer”).

The Supplementary Prospectus relates to the publication of the annual report and financial statements of the Company for the year ended 31 December 2021 on 25 March 2022.

The Supplementary Prospectus has been approved by the Financial Conduct Authority, and copies will shortly be available for inspection at the National Storage Mechanism, which is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism, and from the Company's website: https://senecavct.co.uk/current-offer/.

The Offer by the Company remains open for the 2021/22 and 2022/23 tax years.

For further information, please contact:

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

Any enquiries in respect of the Offer should be directed to:

Siobhan PycroftSeneca Partners Limited01942 295 981Siobhan.Pycroft@senecapartners.co.uk

1 Year Bioscience Vct Chart

1 Year Bioscience Vct Chart

1 Month Bioscience Vct Chart

1 Month Bioscience Vct Chart